Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06910696

Erector Spinae Plane Block Versus Modified Thoracolumbar Interfascial Plane Block

Erector Spinae Plane Block Versus Modified Thoracolumbar Interfascial Plane Block for Rapid Recovery and Rehabilitation After Lumber Discectomy: A Randomized Study

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
144 (estimated)
Sponsor
Zagazig University · Other Government
Sex
All
Age
21 Years – 64 Years
Healthy volunteers
Not accepted

Summary

the purpose of this study is to compare of better postoperative analgesia following lumber spine discectomy

Conditions

Interventions

TypeNameDescription
DRUGRegional Anesthetic InjectionThe probe will be placed in the parasagittal plane at the level of the L3 vertebrae. The spinous process will be visualized, and the probe was moved 3 cm laterally from the midline. The erector spinae musclewill be visualized above the transverse process. The needle will be punctured in the craniocaudal direction using the in-plane technique. The needle will be directed superior to the transverse process . Then, 2 mL normal saline solution will be injected into the deep fascia of the erector spinae muscle to confirm the proper injection site. After ensuring the location of the needle, 20 mL of 0.25% bupivacaine will be administered. The same ESPB procedure will be performed on the other side. In total, 40 mL of 0.25% bupivacaine was administered
DRUGRegional Anesthetic InjectionThe probe will be placed vertically at the L3 vertebrae level. The spinous process and the interspinous muscles (i.e., multifidus, longissimus, and iliocostalis) will be visualized as the anatomic guide points. The probewill be moved laterally to identify the longissimus and iliocostalis muscles . The needlewill be inserted between the longissimus and iliocostalis in the medial-to-lateral direction using the in-plane technique. After confirming the location of the needle, 20 mL of 0.25% bupivacaine will be administered. The same mTLIP procedure will be performed on the opposite side. In total, 40 mL of 0.25% bupivacaine will be administered

Timeline

Start date
2025-04-11
Primary completion
2025-09-01
Completion
2025-12-01
First posted
2025-04-04
Last updated
2025-04-15

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06910696. Inclusion in this directory is not an endorsement.